J. Li et al. / Tetrahedron Letters 49 (2008) 2128–2131
2131
´
2. Herrerıas, C. I.; Yao, X.; Li, Z.; Li, C.-J. Chem. Commun. 2007, 107,
pH ꢀ 5–6. Concentration under reduced pressure, followed by
chromatography (SiO2, MeCN–H2O = 10:1–5:1) gave product 4e
(20 mg, 74%): 1H NMR (MeOH-d4) d 4.57 (1H, s), 3.86–3.93 (3H, m),
1.71–1.96 (8H, m); 13C NMR (MeOH-d4) d 193.91, 177.50, 174.52,
96.17, 67.34, 62.80, 30.64, 30.50, 26.83; ESIMS 226.0 [M+1]+.
Compound 5: 1H NMR (MeOH-d4) d (ppm) 4.60 (1H, s), 3.85–3.98
(3H, m), 2.46 (2H, m), 2.23 (2H, m), 1.85 (2H, m); ESIMS 213.0
[M+D]+. Compound 6: (Two diastereomers) 1H NMR (MeOH-d4) d
(ppm) 4.62 (1H, s), 3.90 (3 H, m), 1.52–1.70 (2H, m); 1.25 (1.5H, s),
1.24 (1.5H, s), 0.86 (1.5H, t, J = 7.2 Hz), 0.85 (1.5H, t, J = 7.2 Hz);
ESIMS 214.0 [M+H]+.
2546–2562.
3. Li, C.-J.; Chen, L. Chem. Soc. Rev. 2006, 35, 68–82.
4. Li, C.-J. Chem. Rev. 1993, 93, 2023–2036.
5. Narayan, S.; Muldoon, J.; Finn, M. G.; Fokin, V. V.; Kolb, H. C.;
Sharpless, K. B. Angew. Chem., Int. Ed. 2005, 44, 3275–3279.
6. Tam, J. P.; Yu, Q.; Lu, Y.-A. J. Am. Chem. Soc. 2001, 123, 2487–
2494.
7. Tam, J. P.; Yu, Q.; Miao, Z. Biopolymers 1999, 51, 311–332.
8. Saxon, E.; Bertozzi, C. R. Science 2000, 2007–2010.
9. Sejwal, P.; Han, Y.; Shah, A.; Luk, Y.-Y. Org. Lett. 2007, 9, 4897–
4900.
10. Yorimitsu, H.; Nakamura, T.; Shinokubo, H.; Oshima, K.; Omoto,
K.; Fujimoto, H. J. Am. Chem. Soc. 2000, 122, 11041–11047.
11. Sigman, M. S.; Jacobsen, E. N. J. Am. Chem. Soc. 1998, 4901–4902.
12. Storer, R. I.; Carrera, D. E.; MacMillan, D. W. C. J. Am. Chem. Soc.
2006, 128, 84–86.
13. Rowland, G. B.; Zhang, H.; Rowland, E. B.; Chennamadhavuni, S.;
Wang, Y.; Antilla, J. C. J. Am. Chem. Soc. 2005, 127, 15696–15697.
14. Huang, Y.; Unni, A. K.; Thadani, A. N.; Rawal, V. H. Nature 2003,
424, 146.
15. Corey, E. J.; Gorgon, M. J. Org. Lett. 1999, 1, 157–160.
16. Stanley, H. E. NATO ASI Ser., Ser. A 1999, 305, 3–31.
17. Turnbull, P.; Moore, H. W. J. Org. Chem. 1995, 60, 644–649.
18. Bellus, D.; Ernst, B. Angew. Chem., Int. Ed. Engl. 1988, 27, 797–827.
19. Dillon, J. L.; Gao, Q.; Dillon, E. A.; Adams, N. Tetrahedron Lett.
1997, 38, 2231–2234.
20. Magomedov, N. A.; Ruggiero, P. L.; Tang, Y. J. Am. Chem. Soc.
2004, 126, 1624–1625.
21. Danheiser, R. L.; Gee, S. K. J. Org. Chem. 1984, 49, 1674–1676.
22. Seio, K.; Miyashita, T.; Sato, K.; Sekine, M. Eur. J. Org. Chem. 2005,
5163–5170.
33. Rate constant measurement: The kinetic studies are conducted in situ
in deuteriated solvents in NMR tubes with 1 to 1 equiv of cyclo-
butenone and amino acids. By assuming a second-order reaction, the
initial rate of reaction was calculated by 1/(Ccyclobutenone) = 2kt + 1/C0,
where k is the rate constant and Ccyclobutenone is the concentration
of cyclobutenone at a given time during the course of the reaction.
For each kinetic studies, the yield of the reaction is calculated from
the isolated pure product of amino acid-substituted cyclobutenone
relative to the cyclobutenones.
34. Wenzel, A. G.; Jacobsen, E. N. J. Am. Chem. Soc. 2002, 12964–12965.
35. Sigman, M. S.; Vachal, P.; Jacobsen, E. N. Angew. Chem., Int. Ed.
2000, 39, 1279–1281.
36. Weigert, F. J.; Roberts, J. D. J. Am. Chem. Soc. 1967, 89, 5962–5963.
37. Wiberg, K. B.; Bader, R. F. W.; Lau, C. D. H. J. Am. Chem. Soc.
1987, 109, 985–1001.
38. Selected analytical data for 4a–4d and 4f–4g. Compound 4a: 1H NMR
(MeOH-d4) d (ppm) 7.60 (1H, dt, J = 7.8, 0.6 Hz), 7.29 (1H, dt,
J = 8.1, 0.6 Hz), 7.06 (1H, s), 6.98–7.03 (2H, m), 4.12 (1H, m), 4.11
(1H, s), 3.42–3.48 (1H, m), 3.10–3.19 (1H, m), 1.57–1.80 (8H, m); 13
C
NMR (MeOH-d4) d 193.63, 177.03, 175.54, 136.97, 128.10, 123.69,
121.30, 118.72, 118.36, 111.25, 110.36, 95.83, 67.00, 61.32, 30.67,
30.25, 28.67, 26.67, 26.64; ESIMS 325.1 [M+1]+. Compound 4b: 1H
NMR (MeOH-d4) d (ppm) 6.97 (2H, dd, J = 7.2, 2.1 Hz), 6.62 (2H,
dd, J = 6.6, 2.1 Hz), 4.29 (1H, s), 4.06 (1H, m), 3.15 (1H, m), 2.85
(1H, m), 1.55–1.69 (8H, m); 13C NMR (MeOH-d4) d 193.83, 177.43,
172.99, 156.45, 130.51, 127.70, 115.25, 96.40, 67.14, 60.32, 37.05,
23. Onaran, M. B.; Comeau, A. B.; Seto, C. T. J. Org. Chem. 2005, 70,
10792–10802.
24. Helal, C. J.; Kang, Z.; Lucas, J. C.; Bohall, B. R. Org. Lett. 2004, 6,
1853–1856.
25. Brand, S.; De Candole, B. C.; Brown, J. A. Org. Lett. 2003, 5, 2343–
2346.
1
30.72, 30.29, 26.67; ESIMS 302.0 [M+H]+. Compound 4c: H NMR
26. Plow, E. F.; Cierniewski, C. S.; Xiao, Z.; Haas, T. A.; Byzova, T. V.
Thromb. Haemostasis 2001, 86, 34–40.
(MeOH-d4) d (ppm) 4.54 (1H, s), 3.50 (1H, s), 3.22 (2H, t, J = 6.9 Hz),
1.60–1.82 (12H, m), 1.49 (2H, m); 13C NMR (MeOH-d4) d 193.64,
178.02, 173.56, 95.50, 67.05, 55.03, 44.95, 31.07, 30.63, 28.77, 26.78,
22.53; ESIMS 267.1 [M+H]+. Compound 4d: 1H NMR (MeOH-d4) d
(ppm) 4.54 (1H, s), 3.78 (2H, s), 1.71–1.87 (8H, m); 13C NMR
(MeOH-d4) d 193.81, 177.90, 173.58, 95.90, 67.2, 67.14, 30.57, 26.77;
ESIMS 196.0 [M+H]+. Compound 4f: 1H NMR (MeOH-d4) d (ppm)
4.55 (1H, s), 4.28 (1H, m), 4.06 (1H, m), 3.60 (1H, m), 1.60–2.30 (12H,
m); ESIMS 236.1 [M+H]+. Compound 4g: 1H NMR (MeOH-d4) d
(ppm) 4.59 (2H, s), 4.10 (2H, m), 3.39 (2H, m), 3.03 (2H, m), 1.71–
1.95 (16H, m); 13C NMR (MeOH-d4) d 193.84, 177.62, 174.82, 96.24,
67.26, 59.67, 40.94, 30.78, 30.37, 26.82; ESIMS 481.1 [M+H]+.
27. Askew, B. C.; Bednar, R. A.; Bednar, B.; Claremon, D. A.; Cook, J.
J.; McIntyre, C. J.; Hunt, C. A.; Gould, R. J.; Lynch, R. J.; Lynch, J.
J., Jr.; Gaul, S. L.; Stranieri, M. T.; Sitko, G. R.; Holahan, M. A.;
Glass, J. D.; Hamill, T.; Gorham, L. M.; Prueksaritanont, T.;
Baldwin, J. J.; Hartman, G. D. J. Med. Chem. 1997, 40, 1779–1788.
28. Lim, N. C.; Morton, M. D.; Jenkins, H. A.; Bruckner, C. J. Org.
Chem. 2003, 68, 83–91.
29. Hasek, R. H.; Gott, P. G.; Martin, J. C. J. Org. Chem. 1964, 29, 2510–
2513.
30. Kohnen, A. L.; Mak, X. Y.; Lam, T. Y.; Dunetz, J. R.; Danheiser, R.
L. Tetrahedron 2006, 62, 3815–3822.
1
Compound 4h: H NMR (MeOH-d4) d (ppm) 4.59 (1H, s), 4.10 (1H,
31. Wasserman, H. H.; Piper, J. U.; Dehmlow, E. V. J. Org. Chem. 1973,
38, 1451–1455.
m), 3.90 (1H, m), 3.40 (2H, m), 3.10 (1H, m), 2.93 (1H, m), 1.69–1.93
(8H, m); 13C NMR (MeOH-d4) d 193.87, 177.49, 174.50, 96.32,
32. General procedure for the substitution reaction of cyclobutenone with
amino acid—3-ethoxyspiro[3.4]-oct-2-en-1-one (2) with L-serine: A
solution 2 (20 mg, 0.12 mmol), L-serine (19 mg, 0.18 mmol), and
NaOH (7.2 mg, 0.18 mmol) in water (0.9 mL) and DMSO (0.1 mL)
was stirred at room temperature for 10 h. The solution was washed
with ether (2.0 mL) twice and then acidified with 1.0 N HCl to
67.35, 59.41, 53.59, 40.59, 39.01, 30.70, 30.42, 26.80; ESIMS 361.0
[M+1]+.
39. Llinas, A.; Vilanova, B.; Page, M. I. J. Phys. Org. Chem. 2004, 17,
521–528.
40. Johnson, E. C. B.; Kent, S. B. H. J. Am. Chem. Soc. 2006, 128, 6640–
6646.